Table 3

Treatment description by age
Age 75-79 (N=310) 80-84 (N=208) ≥85 (N=163) p value* All cases (N=681)
Treatments 310 % 208 % 163 % 681 %
No treatment 0.006
Yes 4 1.3 6 2.9 9 5.5 19 2.8
No 304 98.1 197 94.7 145 89.0 646 94.9
Unknown 2 0.6 5 2.4 9 5.5 16 2.3
Surgery alone 0.02
Yes 19 6.1 13 6.3 20 12.3 52 7.6
No 272 87.7 184 88.5 126 77.3 582 85.5
Unknown 19 6.1 11 5.3 17 10.4 634 93.1
Hormone therapy <0.001
Yes 12 3.9 18 8.7 44 27.0 74 10.9
No 277 89.4 176 84.6 93 57.1 546 80.2
Unknown 21 6.8 14 6.7 26 16.0 61 9.0

Breast conserving surgery plus

adjuvant therapy

<0.001
Yes 144 46.5 69 33.2 25 15.3 238 34.9
No 157 50.6 135 64.9 132 81.0 424 62.3
Unknown 9 2.9 4 1.9 6 3.7 19 2.8
Mastectomy plus adjuvant therapy 0.40
Yes 92 29.7 83 39.9 36 22.1 211 31.0
No 208 67.1 116 55.8 116 71.2 440 64.6
Unknown 10 3.2 9 4.3 11 6.7 30 4.4
Others† 0.03
Yes 18 5.8 5 2.4 3 1.8 26 3.8
No 271 87.4 189 90.9 134 82.2 594 87.2
Unknown 21 6.8 14 6.7 26 16.0 61 9.0

Abbreviations: N = number of patients.

*Cochran-Armitage trend test.

†Others: chemotherapy alone, radiotherapy alone, chemotherapy plus hormone therapy, chemotherapy plus radiotherapy, radiotherapy plus hormone therapy, chemotherapy plus radiotherapy plus hormone therapy, neoadjuvant chemotherapy plus surgery plus adjuvant therapy, neoadjuvant chemotherapy plus surgery.

Dialla et al.

Dialla et al. BMC Cancer 2012 12:472   doi:10.1186/1471-2407-12-472

Open Data